Try our beta test site
22 studies found for:    Duke Psychiatry | Open Studies | United States, North Carolina
Show Display Options
Rank Status Study
1 Recruiting Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD
Condition: Attention-Deficit/Hyperactivity Disorder
Intervention: Drug: Methylphenidate HCl ER Capsules
2 Recruiting Pain Management Using Mobile Technology in Veterans With PTSD and TBI
Conditions: Chronic Pain;   Posttraumatic Stress Disorders;   Traumatic Brain Injury
Intervention: Device: NeuroSky MindWave Mobile
3 Recruiting Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
4 Recruiting Carolina Alcohol and Drug Resources
Condition: HIV
Intervention: Behavioral: Comprehensive substance abuse services
5 Recruiting Hepatitis C Alcohol Reduction Treatment
Condition: Hepatitis C, Chronic; AUD
Interventions: Behavioral: Brief alcohol counseling;   Behavioral: Group and Individual Therapy Sessions
6 Recruiting Mobile Health Application for Family and Behavioral Health Provider Communication
Conditions: Posttraumatic Stress Disorder;   Anger
Intervention: Behavioral: Connectd mobile application
7 Recruiting Feeling and Body Investigators
Condition: Functional Abdominal Pain
Interventions: Behavioral: Feeling and Body Investigators with Functional Abdominal Pain;   Behavioral: Treatment Strategies
8 Not yet recruiting A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: Aptensio XR
9 Not yet recruiting A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: Aptensio XR;   Drug: Placebo
10 Recruiting Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a
Condition: ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
Interventions: Drug: CERC-501;   Drug: placebo
11 Recruiting Post Admission Cognitive Therapy (PACT) for the Inpatient Treatment of Military Personnel With Suicidal Behaviors
Conditions: Suicide, Attempted;   Suicidal Ideation Active
Intervention: Behavioral: Post Admission Cognitive Therapy (PACT)
12 Recruiting Software Treatment for Actively Reducing Severity of ADHD - Follow Up
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Device: EVO
13 Recruiting Software Treatment for Actively Reducing Severity of ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Device: EVO
14 Recruiting Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)
Condition: Obsessive Compulsive Disorder
Interventions: Drug: sertraline;   Behavioral: psychotherapy
15 Recruiting MOMENTUM 3 Continued Access Protocol
Condition: Advanced Refractory Left Ventricular Heart Failure
Intervention: Device: HeartMate 3 LVAS
16 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
17 Recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Biological: PF-06252616;   Drug: Placebo
18 Recruiting Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson Disease
Interventions: Drug: Placebo;   Drug: PF-06649751 low dose;   Drug: PF-06649751 middle dose level 1;   Drug: PF-06649751 middle dose level 2;   Drug: PF-06649751 high dose
19 Recruiting A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)
Condition: Autism
Interventions: Drug: CM-AT;   Drug: PLACEBO
20 Recruiting Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Drug: SPD489

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.